Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors
Infections represent a significant cause of morbidity and mortality in cancer patients. Multiple factors related to the patient, tumor, and cancer therapy can affect the risk of infection in patients with solid tumors. A thorough understanding of such factors can aid in the identification of patient...
Main Authors: | Ondřej Kubeček, Pavla Paterová, Martina Novosadová |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/12/1387 |
Similar Items
-
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
by: Qing Wei, et al.
Published: (2024-01-01) -
Mutations in the Serine/Threonine Kinase BRAF: Oncogenic Drivers in Solid Tumors
by: Paola Roa, et al.
Published: (2024-03-01) -
CAR T-Cell Therapy in Children with Solid Tumors
by: Marika Kulczycka, et al.
Published: (2023-03-01) -
Tyrosine kinase receptor inhibitor as a molecularly targeted therapy for solid tumors
by: P Sunpaweravong
Published: (2006-01-01) -
Clinical Trials of Cellular Therapies in Solid Tumors
by: Simona Secondino, et al.
Published: (2023-07-01)